Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 101 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7579357

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted

  2. US 7576065

    Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted

  3. US 7572914

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  4. US 7569580

    Heterotricyclic compounds for use as HCV inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  5. US 7569591

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  6. US 7566719

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  7. US 7557106

    Substituted pyrimidines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  8. US 7553852

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  9. US 7550590

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  10. US 7550598

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  11. US 7547794

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  12. US 7547698

    Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

    Xenon Pharmaceuticals Inc. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  13. US 7541381

    Non-covalent inhibitors of AmpC β-lactamase

    Northwestern University · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  14. US 7531570

    Treatment of diseases using ICE inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  15. US 7531556

    Compositions useful as inhibitors of rock and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  16. US 7531536

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  17. US 7527934

    Labeled substrate conjugates for identifying enzyme inhibitors

    The Regents of the University of California · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  18. US 7528138

    Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  19. US 7528142

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  20. US 7521475

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  21. US 7521049

    Use of VEGF inhibitors for treatment of eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  22. US 7517987

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  23. US 7514448

    Azaindoles useful as inhibitors of rock and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  24. US 7511038

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.